Arcellx Inc (ACLX) earnings · rev $107.9M
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
This ACLX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
When the next ACLX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 2.2% from 2023-12-31 to 2024-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ACLX research stays on the stock page; the tape stays on the quote page.
Not investment advice.